Bradley, J. D., Paulus, R., Komaki, R., Masters, G., Blumenschein, G., Schild, S., Bogart, J., Hu, C., Forster, K., Magliocco, A., Kavadi, V., Garces, Y. I., Narayan, S., Iyengar, P., Robinson, C., Wynn, R. B., Koprowski, C., Meng, J., Beitler, J., Gaur, R., Curran, W., & Choy, H. (n.d.). standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet oncology, 16(2), 187–199. http://access.bl.uk/ark:/81055/vdc_100025998197.0x000055